Kraus D, Yang Q, Kong D, Banks AS, Zhang L, Rodgers JT, Pirinen E, Pulinilkunnil TC, Gong F, Wang YC, Cen Y, Sauve AA, Asara JM, Peroni OD, Monia BP, Bhanot S, Alhonen L, Puigserver P, Kahn BB. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature. 2014 Apr 10;508(7495):258-62. doi: 10.1038/nature13198. PMID: 24717514; PMCID: PMC4107212
There is no official clinical guidance, published interaction data, or regulatory framework governing the combined use of AOD 9604 and retatrutide
Low levels have been linked with symptoms such as low mood, increased anxiety, irritability, and mood swings
J Clin Endocrinol Metab 88 : 43714378 Segerlantz M et al
Visible body composition changes typically emerge around week 3-4, with significant fat loss and waist circumference reduction becoming apparent by weeks 5-8
Clinical trial investigating for obesity treatment